To reinstate and extend the deadline for commencement of construction of a hydroelectric project involving Jennings Randolph Dam.
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
98pct
454d open
vs 7,393 other HR bills in the 115th — cohort avg 50d
(Sec.1)This bill authorizes the Federal Energy Regulatory Commission (FERC), upon request, to extend for up to six years the time period during which construction must commence on the Jennings Randolph Hydroelectric Project located on the North Branch of the Potomac River in Garrett County, Maryland, and Mineral County, West Virginia. Additionally, FERC may reinstate the construction license if it is expired.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (2)
2018 · third_quarter · Energy/Nuclear
Federal legislation to extend construction deadlines under the Federal Power Act, including H.R. 2122 and S. 710
Client expense: Not reported · Firm income: Not reported
Became Public Law No: 115-205.
Became Public Law No: 115-205.
Signed by President.
Signed by President.
Presented to President.
Presented to President.
Message on Senate action sent to the House.
Passed Senate without amendment by Unanimous Consent. (consideration: CR S4810)
Passed/agreed to in Senate: Passed Senate without amendment by Unanimous Consent.(consideration: CR S4810)
Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 138.
Motion to reconsider laid on the table Agreed to without objection.
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · second_quarter · Energy/Nuclear
Federal legislation to extend construction deadlines under the Federal Power Act, including H.R. 2122 and S. 710
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · first_quarter · Energy/Nuclear
Federal legislation to extend construction deadlines under the Federal Power Act, including H.R. 2122 and S. 710
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2017 · fourth_quarter · Medicare/Medicaid
Communication with Center for Medicare and Medicaid Services regarding Innovation Center, direct reimbursement under Medicare Program, annual payment updates, and PMB transparency. Support for H.R. 592/S. 109, legislation that would amend title 18 of the Social Security Act to provide for coverage of pharmacist services under the Medicare Program. Discussion with House and Senate about increased prescription drug pricing. Communication on Direct and Indirect Remuneration fees (DIR) under Medicare Part D. Support for H.R. 2122/S. 974, a bill that would promote competition by limiting a manufacturers ability to prevent potential competitors from entering the market. Support for behavioral health funding and service expansion; communication on maintaining the 340B program.
Client expense: $190,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2017 · third_quarter · Medicare/Medicaid
Communication with Center for Medicare and Medicaid Services regarding Innovation Center, direct reimbursement under Medicare Program, annual payment updates, and PMB transparency. Support for H.R. 592/S. 109, legislation that would amend title 18 of the Social Security Act to provide for coverage of pharmacist services under the Medicare Program. Discussion with House and Senate about increased prescription drug pricing. Communication on Direct and Indirect Remuneration fees (DIR) under Medicare Part D. Support for H.R. 2122/S. 974, a bill that would promote competition by limiting a manufacturers ability to prevent potential competitors from entering the market. Support for behavioral health funding and service expansion.
Client expense: $240,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE
2017 · fourth_quarter · Medicare/Medicaid
Communication with Center for Medicare and Medicaid Services regarding Innovation Center, direct reimbursement under Medicare Program, annual payment updates, and PMB transparency. Support for H.R. 592/S. 109, legislation that would amend title 18 of the Social Security Act to provide for coverage of pharmacist services under the Medicare Program. Discussion with House and Senate about increased prescription drug pricing. Communication on Direct and Indirect Remuneration fees (DIR) under Medicare Part D. Support for H.R. 2122/S. 974, a bill that would promote competition by limiting a manufacturers ability to prevent potential competitors from entering the market. Support for behavioral health funding and service expansion; communication on maintaining the 340B program.
Client expense: $60,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2017 · fourth_quarter · Energy/Nuclear
Federal legislation to extend construction deadlines under the Federal Power Act, including H.R. 2122 and S. 710
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2017 · third_quarter · Medicare/Medicaid
Communication with Center for Medicare and Medicaid Services regarding Innovation Center, direct reimbursement under Medicare Program, annual payment updates, and PMB transparency. Support for H.R. 592/S. 109, legislation that would amend title 18 of the Social Security Act to provide for coverage of pharmacist services under the Medicare Program. Discussion with House and Senate about increased prescription drug pricing. Communication on Direct and Indirect Remuneration fees (DIR) under Medicare Part D. Support for H.R. 2122/S. 974, a bill that would promote competition by limiting a manufacturers ability to prevent potential competitors from entering the market. Support for behavioral health funding and service expansion.
Client expense: $130,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE
2017 · third_quarter · Medicare/Medicaid
Communication with Center for Medicare and Medicaid Services regarding Innovation Center, direct reimbursement under Medicare Program, annual payment updates, and PMB transparency. Support for H.R. 592/S. 109, legislation that would amend title 18 of the Social Security Act to provide for coverage of pharmacist services under the Medicare Program. Discussion with House and Senate about increased prescription drug pricing. Communication on Direct and Indirect Remuneration fees (DIR) under Medicare Part D. Support for H.R. 2122/S. 974, a bill that would promote competition by limiting a manufacturers ability to prevent potential competitors from entering the market. Support for behavioral health funding and service expansion.
Client expense: $115,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE
2017 · third_quarter · Energy/Nuclear
Federal legislation to extend construction deadlines under the Federal Power Act, including H.R. 2122 and S. 710
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2017 · second_quarter · Energy/Nuclear
Federal legislation to extend construction deadlines under the Federal Power Act, including H.R. 2122 and S. 710
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H4828)
Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote.(text: CR H4828)
DEBATE - The House proceeded with forty minutes of debate on H.R. 2122.
Considered under suspension of the rules. (consideration: CR H4828)
Mr. Upton moved to suspend the rules and pass the bill.
Placed on the Union Calendar, Calendar No. 119.
Reported by the Committee on Energy and Commerce. H. Rept. 115-175.
Congress.gov source codes: 5000, H12200
Subcommittee on Energy Discharged.
Ordered to be Reported by Unanimous Consent.
Committee Consideration and Mark-up Session Held.
Referred to the Subcommittee on Energy.
Referred to the House Committee on Energy and Commerce.
Introduced in House
Congress.gov source codes: 1000, Intro-H
| June 12, 2017 |
| Introduced in House | April 25, 2017 |
| Enrolled Bill | -- |